Diabetes

Prediabetes: You Probably Have It and Don’t Know

The Pin Health Staff Writer

February 16, 2026 16 min read

One in three adults has prediabetes. More than 80% of them don't know it. That's not because it's rare or hard to find — it's because almost nobody is looking for it in the right way, at the right time.

There’s a metabolic condition that affects roughly one in three adults. It dramatically increases the risk of type 2 diabetes, heart disease, stroke, and kidney damage. It has no obvious symptoms. And more than 80% of the people who have it are completely unaware.

That condition is prediabetes — the stage where blood sugar regulation has already begun to fail but hasn’t yet crossed the threshold for a diabetes diagnosis. It’s not a pre-condition in the trivial sense. It’s an active metabolic state where damage is already accumulating in blood vessels, nerves, and organs. The label “pre” makes it sound like nothing has happened yet. In reality, quite a lot has.

The tragedy of prediabetes isn’t that it’s untreatable — it’s that it’s largely ignored. Most people with prediabetes receive no diagnosis, no treatment, and no guidance. They find out they have a metabolic problem only when it progresses to full type 2 diabetes, by which point years of preventable damage have already occurred.

This article explains what prediabetes actually is, why it goes undetected so often, what’s happening inside your body during this stage, and — most importantly — how to catch it early and reverse it before it progresses.

What Prediabetes Actually Means

To understand prediabetes, you need to understand the spectrum of blood sugar regulation. It’s not a binary switch between “normal” and “diabetic.” Instead, it’s a gradual continuum that develops over years:

Healthy metabolism: Your pancreas produces insulin in response to food. Cells respond efficiently, absorbing glucose from the blood. Blood sugar rises modestly after eating, then returns to baseline within a couple of hours. Insulin levels stay relatively low because the system is working smoothly.

Early insulin resistance: Cells begin responding less effectively to insulin. The pancreas compensates by producing more. Blood sugar remains normal, but insulin levels are climbing. This stage can last for years, and standard blood tests typically detect nothing abnormal. Nevertheless, the metabolic machinery is already straining.

Prediabetes: The pancreas can no longer fully compensate. Blood sugar starts rising above normal levels — not enough for a diabetes diagnosis, but enough to indicate that the system is failing. At this point, damage to blood vessels and organs has already begun. However, the condition is still largely reversible with appropriate intervention.

Type 2 diabetes: The pancreas cannot produce enough insulin to overcome resistance. Blood sugar is persistently elevated. Organ damage accelerates. While still manageable, full reversal becomes significantly more difficult — and for some people, impossible without ongoing medication.

The critical insight is this: prediabetes is not a waiting room. It’s an active disease state with real metabolic consequences. Moreover, it’s the last stage where intervention is most effective and reversal is most achievable. Missing this window means confronting a far harder problem later.

Why 80% of Cases Go Undetected

If prediabetes is so common and so consequential, why does the vast majority of it go undiagnosed? Several factors converge to create this blind spot:

No symptoms — until there are

Prediabetes produces no pain, no dramatic symptoms, and no obvious warning signs in most people. Blood sugar levels are elevated enough to cause damage but not elevated enough to make you feel obviously sick. You don’t feel your blood vessels stiffening. You don’t feel your pancreas struggling. As a result, there’s no trigger to seek testing — people feel fine right up until they don’t.

Some people do experience subtle signs: increased thirst, more frequent urination, fatigue after meals, difficulty concentrating, or slow wound healing. These symptoms, however, develop so gradually that they’re almost always attributed to aging, stress, poor sleep, or simply “how things are.” They’re rarely interpreted as metabolic red flags.

Standard screening is too late and too narrow

Current guidelines recommend diabetes screening starting at age 35 for adults with a healthy BMI, or earlier if risk factors are present. In practice, many people aren’t screened regularly — and when they are, the test used is often fasting glucose alone.

Fasting glucose is the last marker to become abnormal in the progression toward diabetes. It only rises after the pancreas has been struggling for years and is finally losing the battle. By the time fasting glucose enters the prediabetic range, metabolic dysfunction has been developing for potentially a decade or more. Consequently, relying on fasting glucose as the primary screening tool is like relying on a smoke alarm that only goes off when the house is already half burned.

HbA1c (a measure of average blood sugar over three months) catches the problem somewhat earlier than fasting glucose. However, even HbA1c doesn’t reveal the earliest stages of dysfunction — when insulin is already elevated but blood sugar is still being held in range through pancreatic compensation.

Fasting insulin — the missing test

The marker that reveals metabolic trouble earliest is fasting insulin. When cells become resistant to insulin’s signal, the pancreas produces more of it to compensate. Fasting insulin rises years — sometimes a decade — before fasting glucose or HbA1c become abnormal. It’s the earliest warning signal available.

Despite this, fasting insulin is rarely included in routine blood panels. It’s not part of standard metabolic screening in most countries. Unless a patient specifically requests it or their provider is metabolically oriented, this critical early marker goes unchecked. This single omission is arguably the biggest reason prediabetes goes undetected for so long.

The BMI blind spot

There’s a widespread assumption that prediabetes and type 2 diabetes only affect people who are visibly overweight. In reality, approximately 20% of people with prediabetes have a normal BMI. This phenomenon — sometimes called “metabolically obese, normal weight” or colloquially “skinny fat” — occurs when visceral fat (around organs) and metabolic dysfunction exist despite a normal-looking body composition.

Furthermore, certain ethnic groups — including South Asian, East Asian, Hispanic, and African American populations — develop insulin resistance at lower body weights than European populations. Using BMI as a gatekeeper for metabolic screening therefore misses a significant proportion of affected individuals.

What Prediabetes Does While You Don’t Know About It

The “pre” in prediabetes suggests that nothing serious has happened yet — that you’re merely at risk. This framing is dangerously misleading. Research consistently shows that significant damage begins during the prediabetic stage, long before a diabetes diagnosis is made.

Cardiovascular damage starts early

Heart disease risk doesn’t suddenly appear when blood sugar crosses the diabetes threshold. In fact, cardiovascular risk begins increasing in the prediabetic range. Elevated blood sugar damages the endothelium (the inner lining of blood vessels), promotes inflammation, accelerates atherosclerotic plaque development, and increases blood pressure. Studies have found that people with prediabetes have roughly a 15-20% higher risk of cardiovascular events compared to those with normal blood sugar — even without progressing to diabetes.

This means that by the time someone receives a diabetes diagnosis, they may have already been accumulating cardiovascular damage for a decade. The damage doesn’t wait for a diagnostic label to begin.

Nerve damage begins before diagnosis

Peripheral neuropathy — tingling, numbness, or pain in the hands and feet — is typically considered a complication of established diabetes. However, research now shows that up to 10-30% of people with prediabetes already have detectable nerve damage. The elevated blood sugar and insulin resistance characteristic of prediabetes are sufficient to begin damaging peripheral nerves, particularly the smallest fibers that detect pain and temperature.

This finding has fundamentally changed how neurologists view diabetic complications. The damage doesn’t begin at diagnosis — it begins during the silent prediabetic years that precede it.

Kidney function may decline

Similarly, subtle kidney damage can begin during prediabetes. The kidneys are highly sensitive to blood sugar levels and to the inflammatory, hypertensive environment that insulin resistance creates. Microalbuminuria — a marker of early kidney damage — has been detected in prediabetic individuals at rates significantly higher than in metabolically healthy people.

The liver takes a hit

Non-alcoholic fatty liver disease (NAFLD) is intimately connected to insulin resistance and frequently coexists with prediabetes. Elevated insulin drives fat accumulation in liver cells, which in turn worsens insulin resistance — creating another self-reinforcing cycle. An estimated 50-70% of people with prediabetes have some degree of fatty liver, though most are unaware of it because the condition is typically asymptomatic until advanced stages.

Inflammation becomes chronic

Prediabetes is an inflammatory state. Insulin resistance promotes the release of inflammatory cytokines from visceral fat and immune cells. These inflammatory molecules — including C-reactive protein, interleukin-6, and tumor necrosis factor-alpha — circulate throughout the body and contribute to damage in virtually every organ system. Chronic inflammation, in turn, worsens insulin resistance, creating a feedback loop that accelerates metabolic decline.

Who Is at Risk?

Certain factors significantly increase the likelihood of developing prediabetes. If several of these apply to you, proactive screening is particularly important:

• Family history — a parent or sibling with type 2 diabetes roughly doubles your risk
• Excess weight, especially around the midsection — visceral fat is the strongest modifiable risk factor
• Sedentary lifestyle — physical inactivity directly reduces insulin sensitivity
• Age over 35 — risk increases progressively with age, though prediabetes is increasingly seen in younger adults
• History of gestational diabetes — women who developed diabetes during pregnancy have a significantly higher lifetime risk
• Polycystic ovary syndrome (PCOS) — strongly linked to insulin resistance
• Certain ethnic backgrounds — South Asian, Hispanic, African American, and Native American populations face elevated risk
• Sleep disorders — particularly obstructive sleep apnea, which independently worsens insulin resistance
• Chronic stress — through sustained cortisol elevation and its metabolic consequences
• History of high blood pressure or abnormal cholesterol — both commonly cluster with insulin resistance

Notably, having none of these risk factors doesn’t guarantee protection. Prediabetes can develop in people who appear outwardly healthy — which is precisely why testing matters more than assumptions.

How to Actually Detect Prediabetes

A truly comprehensive metabolic screening goes beyond what most routine checkups provide. To catch prediabetes at its earliest — and most reversible — stage, the following markers together provide the clearest picture:

Fasting insulin. This is the earliest warning signal. Elevated fasting insulin indicates that your pancreas is working harder than it should to maintain normal blood sugar. If this marker is elevated while glucose is still normal, you’re in the compensated insulin resistance phase — the ideal time to intervene.

Fasting glucose. A useful baseline, but as discussed, it’s the last marker to become abnormal. A normal fasting glucose does not rule out metabolic dysfunction.

HbA1c. Reflects average blood sugar over the preceding two to three months. More informative than a single fasting glucose reading because it captures fluctuations that fasting glucose misses. An HbA1c in the upper range of normal, while not diagnostic, may warrant further investigation — especially if fasting insulin is also elevated.

Triglycerides and HDL. The triglyceride-to-HDL ratio is a practical and widely available surrogate marker for insulin resistance. When triglycerides are elevated and HDL is low, the pattern strongly suggests metabolic dysfunction — even when glucose numbers look acceptable.

C-reactive protein (CRP). Measures systemic inflammation. Chronically elevated CRP in the context of other metabolic markers supports the picture of insulin resistance and its inflammatory consequences.

Uric acid. Often elevated in the setting of insulin resistance and metabolic syndrome. It’s an underappreciated marker that adds diagnostic value when interpreted alongside the others.

The key principle is that no single marker tells the full story. Fasting glucose can be normal while insulin is dangerously elevated. HbA1c can be borderline while triglycerides reveal a clear metabolic pattern. A comprehensive panel — not a single number — is what catches prediabetes early enough to reverse it.

The Evidence on Reversal: What Actually Works

The most important thing about prediabetes is that it doesn’t have to progress. Large-scale clinical trials have demonstrated conclusively that lifestyle intervention can prevent or significantly delay the onset of type 2 diabetes — and in many cases, fully reverse prediabetes to normal metabolic health.

The landmark Diabetes Prevention Program (DPP) trial followed over 3,000 participants with prediabetes. Those randomized to an intensive lifestyle intervention — focused on modest weight loss, dietary changes, and regular physical activity — reduced their risk of progressing to type 2 diabetes by 58% compared to the control group. In participants over 60, the reduction was even greater: 71%. Importantly, the lifestyle intervention outperformed medication (metformin), which reduced risk by 31%.

Follow-up studies showed that these benefits persisted for over a decade. Participants who maintained lifestyle changes continued to have significantly lower diabetes rates years after the initial trial ended. In other words, the reversal wasn’t temporary — it was durable when the changes were sustained.

What the interventions actually involved

The lifestyle changes that proved effective in clinical trials weren’t extreme. They didn’t require radical diets or marathon training. The core components were straightforward:

Modest weight loss. Losing approximately 5-7% of body weight produced dramatic metabolic improvements. For someone weighing 90 kg, that’s roughly 5-6 kg — an achievable target for most people. The weight loss didn’t need to be dramatic to be metabolically transformative.

Regular physical activity. The target was 150 minutes per week of moderate-intensity exercise — essentially 30 minutes of brisk walking, five days a week. No gym membership required. The metabolic benefit came from consistent movement, not intense training.

Dietary restructuring. Reducing refined carbohydrates and processed foods, increasing vegetables and fiber, choosing whole foods over packaged ones, and building meals around protein and healthy fats. These changes reduce the insulin demand on the pancreas — which is the fundamental mechanism behind reversal.

Sustained consistency. The interventions that worked weren’t short-term diet programs. They were sustained behavioral changes that participants maintained over months and years. Prediabetes reversal isn’t about a 30-day challenge — it’s about shifting the baseline of how you eat and move permanently.

When medication adds value

For some individuals — particularly those with more advanced prediabetes, those who have difficulty implementing lifestyle changes, or those with additional risk factors — medication can provide meaningful benefit alongside lifestyle intervention.

Metformin remains the most studied and widely used medication for prediabetes prevention. It reduces hepatic glucose production and modestly improves insulin sensitivity. While less effective than lifestyle changes in the DPP trial, it still reduced diabetes progression by 31% — a significant benefit, especially for people who struggle with lifestyle modification alone.

More recently, GLP-1 receptor agonists have shown substantial metabolic benefits, including significant weight loss, improved insulin sensitivity, and cardiovascular risk reduction. These medications are particularly relevant for people with prediabetes who also have obesity or cardiovascular risk factors. However, they work most effectively as part of a comprehensive approach — not as a substitute for the foundational lifestyle changes that address the root cause.

The Psychological Dimension

A prediabetes diagnosis can provoke anxiety — and understandably so. The word “diabetes” carries significant emotional weight. However, reframing the diagnosis is essential: prediabetes isn’t a verdict. It’s a warning with a clear path to resolution.

Many people who discover they have prediabetes actually describe it as a turning point — the concrete, objective piece of information that motivated changes they’d been considering for years. Vague advice to “eat better and exercise more” is easy to defer. A metabolic marker showing your body is losing its ability to regulate blood sugar creates urgency that abstractions cannot.

Furthermore, the reversibility of prediabetes is genuinely encouraging. Unlike many chronic conditions, this is one where lifestyle changes produce measurable, relatively rapid improvements. Most people who commit to the evidence-based interventions described above see meaningful changes in their metabolic markers within three to six months. That kind of feedback loop — effort producing visible results — is psychologically powerful and self-reinforcing.

Taking Action: A Clear Path Forward

Step 1: Get properly tested. Don’t settle for fasting glucose alone. Request fasting insulin, HbA1c, a lipid panel including triglycerides and HDL, CRP, and fasting glucose together. This combination reveals metabolic dysfunction at its earliest and most treatable stage.

Step 2: Know your baseline. If markers suggest prediabetes or insulin resistance, you now have a starting point — not a death sentence. Every marker that’s abnormal is a marker that can improve with the right intervention.

Step 3: Restructure, don’t just restrict. Shift what you eat, not just how much. Prioritize protein and healthy fats, choose complex carbohydrates over refined ones, reduce sugar-sweetened beverages, and minimize ultra-processed foods. These changes reduce insulin demand — the fundamental driver of the problem.

Step 4: Move consistently. Aim for regular moderate exercise — walking counts. Add resistance training if possible. Incorporate post-meal movement. Consistency matters far more than intensity.

Step 5: Address sleep and stress. Both directly affect insulin sensitivity. Improving sleep duration and quality, and finding sustainable ways to manage stress, are metabolic interventions — not optional lifestyle upgrades.

Step 6: Retest in three to six months. Track your progress objectively. Improving markers confirm your approach is working. Stagnant markers signal that adjustments are needed — possibly including medication support. Either way, you’re making decisions based on data, not guesswork.

The window for reversal doesn’t stay open forever. But right now — at the prediabetic stage — it’s wide open. The research is clear. The interventions are proven. The question is simply whether you know to look.

---

Key Takeaways

• Prediabetes affects roughly 1 in 3 adults — and more than 80% of them are unaware
• It’s not a pre-condition — it’s an active metabolic state where cardiovascular, nerve, kidney, and liver damage are already accumulating
• Fasting glucose is the last marker to become abnormal — relying on it alone misses years of detectable dysfunction
• Fasting insulin is the earliest warning signal — and it’s rarely included in routine screening
• Normal BMI doesn’t equal metabolic health — approximately 20% of prediabetes cases occur in normal-weight individuals
• Cardiovascular risk increases during prediabetes — not just after a diabetes diagnosis
• Lifestyle intervention reduces diabetes progression by 58% — outperforming medication in clinical trials
• Modest changes produce major results — 5-7% weight loss and 150 minutes of weekly activity are sufficient
• Reversal is achievable for most people — but the window is most effective during prediabetes, not after diabetes develops
• Comprehensive blood testing catches it earliest — fasting insulin, HbA1c, triglycerides, and CRP together reveal what fasting glucose alone cannot